United States · FDA National Drug Code directory

BRIVARACETAM

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 76282-823_4e622d80-7a5d-47e4-9346-9509be1a2649
Product NDC: 76282-823
Form: TABLET, FILM COATED
Composition / generic term: BRIVARACETAM
Labeler: Exelan Pharmaceuticals, Inc
Marketing category: ANDA
Marketing start / end (source format): 20260728
Source listing expiry: 20271231

Source-listed ingredients

BRIVARACETAM — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

Package details are not available in this snapshot.

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →